Table 1.
Ovarian cancer-specific death N = 177 |
No deaths specific to ovarian cancer N = 112 |
|
---|---|---|
Mean Age, years (±SD) | 61.4 (±11.81) | 57.7 (±11.40) |
Mean time between sampling and diagnosis, months (±SD) | 24.5 (±18.55) | 27.1 (±18.53) |
Mean follow-up time, years (±SD) | 2.7 (±3.06) | 12.5 (±6.23) |
C-reactive protein (mg/L) | ||
Mean, mg/L (±SD) | 11.67 (±20.41) | 7.11 (±10.22) |
<10 mg/L, n (%) | 139 (78.5%) | 94 (83.9%) |
≥10 mg/L, n (%) | 38 (21.5%) | 18 (16.1%) |
Albumin (g/L) | ||
Mean, g/L (±SD) | 41.54 (±3.03) | 41.76 (±3.02) |
<40 g/L, n %) | 35 (19.8%) | 20 (17.9%) |
≥40 g/L, n (%) | 136 (76.8%) | 86 (76.8%) |
Missing, n (%) | 6 (3.4%) | 6 (5.4%) |
Leukocytes (x109 cells/L) | ||
Mean, x109 cells/L (±SD) | 6.80 (±1.86) | 6.99 (±2.02) |
<10 × 109 cells/L, n (%) | 85 (48.0%) | 58 (51.8%) |
≥10 × 109 cells/L, n (%) | 4 (2.3%) | 4 (3.6%) |
Missing, n (%) | 88 (49.7%) | 50 (44.6%) |
Haptoglobin (g/L) | ||
Mean, g/L (±SD) | 1.31 (±0.55) | 1.12 (±0.37) |
<1.4 g/L, n (%) | 72 (40.7%) | 59 (52.7%) |
≥1.4 g/L, n (%) | 34 (19.2%) | 11 (9.8%) |
Missing, n (%) | 71 (40.1%) | 42 (37.5%) |